Clinical Trial: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer

Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Observational

Official Title: Development of a Risk Model Predicting Chemotherapy-induced Grade 3-4 Neutropenia by Paclitaxel/Carboplatin in Epithelial Ovarian Cancer: Prospective Observational Study f

Brief Summary: To develop a robust prediction model to predict the occurrence of grade 3-4 neutropenia induced by adjuvant paclitaxel/carboplatin chemotherapy in patients with epithelial ovarian cancer and to validate this model.

Detailed Summary:
Sponsor: Asan Medical Center

Current Primary Outcome: Risk prediction model for grade 3-4 chemotherapy induced neutropenia [ Time Frame: 1 year ]

Original Primary Outcome: Same as current

Current Secondary Outcome: The association between mannose-binding lectin 2 gene SNP and neutropenia [ Time Frame: 1 year ]

Original Secondary Outcome: Same as current

Information By: Asan Medical Center

Dates:
Date Received: September 4, 2012
Date Started: September 2012
Date Completion:
Last Updated: September 8, 2012
Last Verified: September 2012